These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31261030)

  • 1. Sotrastaurin attenuates the stemness of gastric cancer cells by targeting PKCδ.
    Yuan Y; Yangmei Z; Rongrong S; Xiaowu L; Youwei Z; Sun S
    Biomed Pharmacother; 2019 Sep; 117():109165. PubMed ID: 31261030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer.
    Wu S; Xie J; Shi H; Wang ZW
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32065219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivo.
    Chen Z; Forman LW; Williams RM; Faller DV
    BMC Cancer; 2014 Feb; 14():90. PubMed ID: 24528676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.
    Lee PC; Fang YF; Yamaguchi H; Wang WJ; Chen TC; Hong X; Ke B; Xia W; Wei Y; Zha Z; Wang Y; Kuo HP; Wang CW; Tu CY; Chen CH; Huang WC; Chiang SF; Nie L; Hou J; Chen CT; Huo L; Yang WH; Deng R; Nakai K; Hsu YH; Chang SS; Chiu TJ; Tang J; Zhang R; Wang L; Fang B; Chen T; Wong KK; Hsu JL; Hung MC
    Cancer Cell; 2018 Dec; 34(6):954-969.e4. PubMed ID: 30537515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop.
    An Y; Wang B; Wang X; Dong G; Jia J; Yang Q
    Cell Death Dis; 2020 Feb; 11(2):115. PubMed ID: 32051395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase Cδ (PKCδ) involved in the regulation of pAkt1 (Ser473) on the release of mouse oocytes from diplotene arrest.
    Liu L; Li S; Li H; Yu D; Li C; Li G; Cao Y; Feng C; Deng X
    Cell Biochem Funct; 2018 Jun; 36(4):221-227. PubMed ID: 29774951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of triazole-based PKC-inhibitors to overcome resistance to EGFR inhibitors in EGFR-mutant lung cancers.
    Lee PC; Kumar V; Sivakumar G; Tseng TY; Li YC; Jiang YC; Hsiao YC; Lin HW; Chang CS; Hung MC
    Am J Cancer Res; 2023; 13(10):4693-4707. PubMed ID: 37970360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKCδ Inhibition Impairs Mammary Cancer Proliferative Capacity But Selects Cancer Stem Cells, Involving Autophagy.
    Berardi DE; Flumian C; Rodriguez CE; Bessone MI; Cirigliano SM; Joffé ED; Fiszman GL; Urtreger AJ; Todaro LB
    J Cell Biochem; 2016 Mar; 117(3):730-40. PubMed ID: 26335446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways.
    Feng S; Zheng Z; Feng L; Yang L; Chen Z; Lin Y; Gao Y; Chen Y
    Oncol Rep; 2016 Dec; 36(6):3207-3214. PubMed ID: 27748935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKC inhibition of sotrastaurin has antitumor activity in diffuse large B-cell lymphoma via regulating the expression of MCT-1.
    Chang G; Zheng J; Xiao W; Chang S; Wei Q; Wu H; Tao Y; Yang G; Xie B; Lan X; Wang Y; Yu D; Hu L; Xie Y; Bu W; Kong Y; Dai B; Hou J; Shi J
    Acta Biochim Biophys Sin (Shanghai); 2018 Apr; 50(4):399-407. PubMed ID: 29534146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs.
    Díaz Bessone MI; Berardi DE; Campodónico PB; Todaro LB; Lothstein L; Bal de Kier Joffé ED; Urtreger AJ
    Breast Cancer Res Treat; 2011 Apr; 126(3):577-87. PubMed ID: 20512658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells.
    Xu ZY; Tang JN; Xie HX; Du YA; Huang L; Yu PF; Cheng XD
    Int J Biol Sci; 2015; 11(3):284-94. PubMed ID: 25678847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells.
    Hung TH; Chen CM; Tseng CP; Shen CJ; Wang HL; Choo KB; Chong KY
    Int J Biochem Cell Biol; 2014 Aug; 53():55-65. PubMed ID: 24814288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric Cancer Stem Cells: Mechanisms and Therapeutic Approaches.
    Fu Y; Du P; Zhao J; Hu C; Qin Y; Huang G
    Yonsei Med J; 2018 Dec; 59(10):1150-1158. PubMed ID: 30450848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.
    Han Y; Cai H; Ma L; Ding Y; Tan X; Chang W; Guan W; Liu Y; Shen Q; Yu Y; Zhang H; Cao G
    Cancer; 2013 Oct; 119(19):3436-45. PubMed ID: 23821160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell.
    Ukai S; Honma R; Sakamoto N; Yamamoto Y; Pham QT; Harada K; Takashima T; Taniyama D; Asai R; Fukada K; Naka K; Tanabe K; Ohdan H; Yasui W
    Oncogene; 2020 Dec; 39(50):7265-7278. PubMed ID: 33046798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.